Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...

GLP-1 drugs have come to be thought of as “wonder drugs,” yet the mechanisms behind their many new health benefits have ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...